Kotak Securities has updated its outlook on Honasa Consumer and Hindustan Aeronautics Limited. Honasa receives a positive upgrade following a 116.5% jump in Q1 FY27 profit, while HAL remains backed by a massive ₹2.55 lakh crore order book. Investors should focus on Honasa's brand scaling and HAL's delivery timelines for defense projects.
Kotak Securities has released updated coverage on two major Indian companies, Hindustan Aeronautics Limited (HAL) and Honasa Consumer, reflecting different growth stories in the defense and consumer goods sectors. The brokerage continues to see potential in both firms, driven by strong operational performance and visibility of future earnings.
Hindustan Aeronautics Limited and Defense Strength
For state-run Hindustan Aeronautics Limited, the brokerage maintains a bullish stance. This view is anchored by a significant order book of ₹2.55 lakh crore as of March 31, 2026. This large backlog provides the company with revenue visibility for the next seven to eight years, largely supported by major defense contracts, including the production of 97 LCA Mk1A aircraft, a deal valued at approximately ₹62,370 crore.
While the financial outlook appears stable, the core investor monitorable remains execution. The company is managing complex manufacturing programs such as the Light Utility Helicopter and the Indian Multi-Role Helicopter. Any supply chain disruptions or delays in the delivery of critical projects like the LCA Mk1A could impact revenue realization timelines. Investors should also note that the company’s performance is closely tied to government defense spending and policy priorities, which can shift over time.
Honasa Consumer’s Strategic Expansion
Honasa Consumer, the parent company of the Mamaearth brand, has seen a positive upgrade from the brokerage following a strong start to the current financial year. In the first quarter of FY27, the company reported a profit-after-tax of ₹90 crore, marking a 116.5% increase compared to the same period last year. Revenue grew by 27% to ₹756 crore, with a like-for-like growth of 31.8%.
A key driver for this performance is the company's evolution from a single-brand entity to a multi-brand powerhouse. For instance, The Derma Co. has successfully scaled to reach an annual recurring revenue of ₹1,000 crore. Furthermore, the company’s profitability has improved, with EBITDA margins expanding to 14.6% in Q1 FY27, compared to 7.7% in the same quarter of the previous year.
Despite this positive momentum, the company faces inherent challenges in the personal care sector. The Indian FMCG landscape is highly competitive, and scaling newer brands requires consistent spending on marketing and distribution. The firm's ability to maintain these improved margins while aggressively growing its offline presence across its network of over 3 lakh outlets will be crucial to track. Investors may also consider the risks associated with institutional shareholding patterns and potential volatility in stock prices that can accompany high-growth consumer companies.